标题
The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer
作者
关键词
Breast cancer, Trastuzumab-resistance, Calcium-signalling, Ca<sub>v</sub>3.2 (<em class=EmphasisTypeItalic >CACNA1H</em>), Therapeutic response, Biomarker
出版物
Cancer Cell International
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-03-31
DOI
10.1186/s12935-016-0299-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells
- (2015) Cale D. Fahrenholtz et al. Oncotarget
- MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
- (2014) Cheng Du et al. BMC CANCER
- Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: Essential role of Cav3.2 channels
- (2014) Elia Ranzato et al. CELL CALCIUM
- L-type Ca2+ channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte
- (2013) Helena M. Viola et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Calcium influx pathways in breast cancer: opportunities for pharmacological intervention
- (2013) I Azimi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Basal/HER2 breast carcinomas
- (2013) Begoña Martin-Castillo et al. CELL CYCLE
- Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib
- (2013) Antonella De Luca et al. CELL CYCLE
- Current Status of Anti–Human Epidermal Growth Factor Receptor 2 Therapies: Predicting and Overcoming Herceptin Resistance
- (2013) Alice Chung et al. Clinical Breast Cancer
- Functional coupling between large-conductance potassium channels and Cav3.2 voltage-dependent calcium channels participates in prostate cancer cell growth
- (2013) Florian Gackière et al. Biology Open
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- CaV1 and CaV2 Channels Engage Distinct Modes of Ca2+ Signaling to Control CREB-Dependent Gene Expression
- (2012) Damian G. Wheeler et al. CELL
- Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
- (2012) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Calcium Channels and Pumps in Cancer: Changes and Consequences
- (2012) Gregory R. Monteith et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells
- (2012) Shu-hua Chu et al. MOLECULAR BIOLOGY REPORTS
- Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer
- (2012) A. A. Peters et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells
- (2012) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson’s Disease
- (2011) Zixiu Xiang et al. ACS Chemical Neuroscience
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
- (2011) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer
- (2011) D. McAndrew et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
- (2010) B. C. Browne et al. ANNALS OF ONCOLOGY
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- A Novel Native Store-operated Calcium Channel Encoded by Orai3
- (2010) Rajender K. Motiani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
- (2010) N. A. O'Brien et al. MOLECULAR CANCER THERAPEUTICS
- PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer
- (2010) J. VanHouten et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acetylcholine induces Ca2+ signaling in chicken retinal pigmented epithelial cells during dedifferentiation
- (2009) Mariko Sekiguchi-Tonosaki et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Orai1 and STIM1 Are Critical for Breast Tumor Cell Migration and Metastasis
- (2009) Shengyu Yang et al. CANCER CELL
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation
- (2008) James T. Taylor et al. CANCER LETTERS
- CaV3.2 T-type Calcium Channels Are Involved in Calcium-dependent Secretion of Neuroendocrine Prostate Cancer Cells
- (2008) Florian Gackière et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium signaling and T-type calcium channels in cancer cell cycling
- (2008) James T Taylor et al. WORLD JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started